Related Experiment Video
Updated: Aug 8, 2026

Histological Quantification of Chronic Myocardial Infarct in Rats
Published on: December 11, 2016
Association between Factor-V Leiden and occurrence of acute myocardial infarction using a large NIS database
Luis Zuniga1, Mitchell Davis2, Mohammad Reza Movahed3,4
1University of Nebraska Medical Center Omaha, NE, USA.
Insights
Factor V Leiden (FVL) is a genetic condition. This study found no significant association between FVL and acute myocardial infarction (AMI) in individuals over 18 years old.
Area of Science:
- Genetics
- Cardiology
- Thrombosis
Background:
- Factor V Leiden (FVL) is an inherited thrombophilia.
- Activated Protein C (APC) resistance is a key feature of FVL.
- The link between FVL and acute myocardial infarction (AMI) remains debated.
Purpose of the Study:
- To investigate the association between Factor V Leiden mutation and acute myocardial infarction.
- To determine if FVL carriers have a higher risk of developing AMI.
Main Methods:
- Retrospective observational analysis using the Nationwide Inpatient Sample (NIS) database.
- Utilized ICD-10 codes to identify patients with APC resistance and AMI.
- Analyzed two populations: 18-40 years and all patients over 18.
Main Results:
- Univariate analysis showed a slight increase in AMI for FVL patients (18-40 group).
- Multivariate analysis, adjusted for age and comorbidities, found no significant association between FVL and AMI (OR 1.44, p=0.117).
- Analysis of the entire population (over 18) also revealed no significant correlation between FVL and AMI.
Conclusions:
- Factor V Leiden mutation is not associated with an increased risk of acute myocardial infarction.
- No correlation was found between FVL and AMI in the studied populations over 18.
- Further research is needed to clarify the relationship between FVL and cardiovascular events.
Abstract:
Factor V Leiden is an inheritable pro-thrombotic genetic condition caused by a point mutation at the 506th codon, resulting in activated protein C resistance. APC resistance has been shown to contribute to the development of venous thrombosis. However, the role of FVL in AMI has yet to be well defined in the current literature. To assess whether a mutation carrier is more apt to develop an AMI, we conducted a retrospective observational analysis of two populations aged 18-40 and 18 through end of life. We used ICD-10 codes to search the NIS, an electronic nationwide patient database, to establish our populations and obtain our data. The ICD-10 codes were specific for activated protein C resistance and acute myocardial infarction. Preliminary data indicated that FVL was related to AMI; however, this finding became insignificant in both populations when stratified for age. We concluded there was no association between Factor V Leiden and acute myocardial infarction across both examined populations. Future investigations into this field of research are warranted as there remains a need for more consensus among the scientific community.
Background:
Medical literature regarding the correlation between Factor V Leiden (FVL) and acute myocardial infarctions (AMI) is controversial. We aim to investigate the association between FVL and AMI.
Materials And Methods:
Using the Nationwide Inpatient Sample database, we evaluated any association between Factor V Leiden and acute myocardial infarction in 2016 using ICD-10 codes.
Results:
Univariate analysis (18-40) showed an increase of AMI in patients with FVL 0.6% vs. 0.4%. However, after adjustment for age and comorbid conditions in multivariate analysis, FVL was not significantly associated with acute myocardial infarction (OR 1.44 (95% CI 0.913-2.273, p-value 0.117)). Univariate analysis (all patients over 18 years old) found that 2.9% of patients with FVL experienced AMI vs. 4.4% without the mutation. Multivariate analysis of the entire population ultimately showed no correlation between FVL and AMI.
Conclusion:
In a population over 18, Factor V Leiden did not correlate with an increased risk of acute myocardial infarction in our studied population.
More Related Videos
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies